...
首页> 外文期刊>Gastroenterology >Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues
【24h】

Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues

机译:自噬释放脂质,该脂质通过激活小鼠和人体组织中的肝星状细胞促进纤维发生

获取原文
获取原文并翻译 | 示例

摘要

Background & Aims: The pathogenesis of liver fibrosis involves activation of hepatic stellate cells, which is associated with depletion of intracellular lipid droplets. When hepatocytes undergo autophagy, intracellular lipids are degraded in lysosomes. We investigated whether autophagy also promotes loss of lipids in hepatic stellate cells to provide energy for their activation and extended these findings to other fibrogenic cells. Methods: We analyzed hepatic stellate cells from C57BL/6 wild-type, Atg7 F/F, and Atg7 F/F-GFAP-Cre mice, as well as the mouse stellate cell line JS1. Fibrosis was induced in mice using CCl 4 or thioacetamide (TAA); liver tissues and stellate cells were analyzed. Autophagy was blocked in fibrogenic cells from liver and other tissues using small interfering RNAs against Atg5 or Atg7 and chemical antagonists. Human pulmonary fibroblasts were isolated from samples of lung tissue from patients with idiopathic pulmonary fibrosis or from healthy donors. Results: In mice, induction of liver injury with CCl 4 or TAA increased levels of autophagy. We also observed features of autophagy in activated stellate cells within injured human liver tissue. Loss of autophagic function in cultured mouse stellate cells and in mice following injury reduced fibrogenesis and matrix accumulation; this effect was partially overcome by providing oleic acid as an energy substrate. Autophagy also regulated expression of fibrogenic genes in embryonic, lung, and renal fibroblasts. Conclusions: Autophagy of activated stellate cells is required for hepatic fibrogenesis in mice. Selective reduction of autophagic activity in fibrogenic cells in liver and other tissues might be used to treat patients with fibrotic diseases.
机译:背景与目的:肝纤维化的发病机制涉及肝星状细胞的活化,这与细胞内脂质滴的消耗有关。当肝细胞进行自噬时,细胞内脂质在溶酶体中降解。我们研究了自噬是否还会促进肝星状细胞中脂质的流失,从而为其活化提供能量,并将这些发现扩展到其他纤维化细胞。方法:我们分析了来自C57BL / 6野生型,Atg7 F / F和Atg7 F / F-GFAP-Cre小鼠的肝星状细胞,以及小鼠星状细胞系JS1。使用CCl 4或硫代乙酰胺(TAA)在小鼠中诱导纤维化。分析肝组织和星状细胞。使用针对Atg5或Atg7的小分子干扰RNA和化学拮抗剂,可以阻断肝脏和其他组织的成纤维细胞中的自噬。从患有特发性肺纤维化的患者或健康供体的肺组织样本中分离出人肺成纤维细胞。结果:在小鼠中,CCl 4或TAA诱导的肝损伤可增加自噬水平。我们还观察到了受损的人肝组织内激活的星状细胞中自噬的特征。培养的小鼠星状细胞和损伤后小鼠的自噬功能丧失会降低纤维发生和基质积累;通过提供油酸作为能量底物,可以部分克服这种影响。自噬还调节胚胎,肺和肾成纤维细胞中成纤维基因的表达。结论:激活的星状细胞自噬是小鼠肝纤维化所必需的。肝脏和其他组织中纤维化细胞中自噬活性的选择性降低可用于治疗患有纤维化疾病的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号